AAAAAA

   
Results: 1-9 |
Results: 9
A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2ISCOMs in mice; cytokine profiles, antibody responses and protection
Authors: Mohamedi, SA Heath, AW Jennings, R
Citation: Sa. Mohamedi et al., A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2ISCOMs in mice; cytokine profiles, antibody responses and protection, ANTIVIR RES, 49(2), 2001, pp. 83-99
Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120
Authors: McCormick, AL Thomas, MS Heath, AW
Citation: Al. Mccormick et al., Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120, J INFEC DIS, 184(11), 2001, pp. 1423-1430
Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection
Authors: Demangel, C Palendira, U Feng, CG Heath, AW Bean, AGD Britton, WJ
Citation: C. Demangel et al., Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection, INFEC IMMUN, 69(4), 2001, pp. 2456-2461
Functional activity of CD40 antibodies correlates to the position of binding relative to CD154
Authors: Barr, TA Heath, AW
Citation: Ta. Barr et Aw. Heath, Functional activity of CD40 antibodies correlates to the position of binding relative to CD154, IMMUNOLOGY, 102(1), 2001, pp. 39-43
Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems
Authors: Mohamedi, SA Brewer, JM Alexander, J Heath, AW Jennings, R
Citation: Sa. Mohamedi et al., Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems, VACCINE, 18(20), 2000, pp. 2083-2094
Therapeutic vaccination against HSV-2: influence of vaccine formulation onimmune responses and protection in mice
Authors: Mohamedi, SA Heath, AW Jennings, R
Citation: Sa. Mohamedi et al., Therapeutic vaccination against HSV-2: influence of vaccine formulation onimmune responses and protection in mice, VACCINE, 18(17), 2000, pp. 1778-1792
Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection inn guinea pigs
Authors: Simms, JR Heath, AW Jennings, R
Citation: Jr. Simms et al., Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection inn guinea pigs, J INFEC DIS, 181(4), 2000, pp. 1240-1248
Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation
Authors: Barr, TA Heath, AW
Citation: Ta. Barr et Aw. Heath, Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation, INFEC IMMUN, 67(7), 1999, pp. 3637-3640
Cell surface expression of CD154 inhibits alloantibody responses: A mechanism for the prevention of autoimmune responses against activated T cells?
Authors: McCormick, AL Santos-Argumedo, L Thomas, MS Heath, AW
Citation: Al. Mccormick et al., Cell surface expression of CD154 inhibits alloantibody responses: A mechanism for the prevention of autoimmune responses against activated T cells?, CELL IMMUN, 195(2), 1999, pp. 157-161
Risultati: 1-9 |